至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Distinctive Roles for Type I and Type II Interferons and Interferon Regulatory Factors in the Host Cell Defense against Varicella-zoster Virus.

J. Virol.. 2018; 
SenNandini,SungPhillip,PandaArjun,ArvinA
Products/Services Used Details Operation
PCR Cloning and Subcloning Stable IRF1 knockout (IRF1KO) HELF and melanoma (Mel39) cells and controls were generated using lentiviruses prepared from transfection of three guide RNAs (gRNA 1-3) targeting IRF1, or a pLentiCRISPRv2 empty vector (gRNA4) (Genscript).The IRF-1 knockout and control cell lines were generated by transfecting IRF-1 CRISPR guide RNA (Table 2) cloned in the pLentiCRISPR vector (GenScript, USA) into HEK293 cells using Lipofectamine 3000 (Thermo Fisher Scientific, USA). Get A Quote

摘要

Both type I and type II interferons (IFNs) have been implicated in the host defense against varicella zoster virus (VZV), a common human herpesvirus that causes varicella and zoster. The purpose of this study was to compare their contributions to the control of VZV replication, to identify the signaling pathways that are critical for mediating their antiviral activity, and to define mechanisms by which the virus counteracts their effects. IFNγ was much more potent than IFNα in blocking VZV infection, which was associated with a differential induction of the interferon regulatory factor (IRF) proteins, IRF1 and IRF9, respectively. These observations account for the clinical experience that while th... More

关键词